ArticleJournal of immunology (Baltimore, Md. : 1950)2024

Cutting Edge: Low-dose Recombinant IL-2 Treatment Prevents Autoantibody Responses in Systemic Lupus Erythematosus via Regulatory T Cell-independent Depletion of T Follicular Helper Cells.

Silvia Santana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.